journal article·2025-06-05

Engineering cell-based ovarian hormone therapy

Maria João Sousa, Christiani A. Amorim

Nature Reviews Bioengineering· Volume 3· Issue 8
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Reproductive Biology and Fertility · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (10)

Show source-provided references
1. Golezar, S., Ramezani Tehrani, F., Khazaei, S., Ebadi, A. & Keshavarz, Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric 22, 403–411 (2019).10.1080/13697137.2019.1574738 ↗
2. Manson, J. E. et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: The women’s health initiative randomized trials. JAMA 318, 927–938 (2017).10.1001/jama.2017.11217 ↗
3. Sittadjody, S. et al. Encapsulation of mesenchymal stem cells in 3d ovarian cell constructs promotes stable and long-term hormone secretion with improved physiological outcomes in a syngeneic rat model. Ann. Biomed. Eng. 48, 1058–1070 (2020).10.1007/s10439-019-02334-w ↗
4. Yoon, H.-J. et al. Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions. Sci. Adv. 7, eabe8873 (2021).10.1126/sciadv.abe8873 ↗
5. Liu, T., Li, Q., Wang, S., Chen, C. & Zheng, J. Transplantation of ovarian granulosa-like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure. Mol. Med. Rep. 13, 5053–5058 (2016).10.3892/mmr.2016.5191 ↗
6. Asiabi, P., Dolmans, M. M., Ambroise, J., Camboni, A. & Amorim, C. A. In vitro differentiation of theca cells from ovarian cells isolated from postmenopausal women. Hum. Reprod. 35, 2793–2807 (2020).10.1093/humrep/deaa246 ↗
7. Sittadjody, S. et al. Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins. Biomaterials 34, 2412–2420 (2013).10.1016/j.biomaterials.2012.11.059 ↗
8. Sittadjody, S. et al. In vivo transplantation of 3D encapsulated ovarian constructs in rats corrects abnormalities of ovarian failure. Nat. Commun. 8, 1858 (2017).10.1038/s41467-017-01851-3 ↗
9. Liu, C. et al. An ovarian cell microcapsule system simulating follicle structure for providing endogenous female hormones. Int. J. Pharm. 455, 312–319 (2013).10.1016/j.ijpharm.2013.07.004 ↗
10. Duke, R. E. et al. A Simple mathematical model demonstrates the potential for cell-based hormone therapy to address dysregulation of the hypothalamus-pituitary-ovary axis in females with loss of ovarian function. Ann. Biomed. Eng. 52, 1894–1907 (2024).10.1007/s10439-023-03307-w ↗